Replies to post #27394 on Ayala Pharmaceuticals Inc (fka ADXS)

[DewDiligence]

...disagree with [Dew] that that is the intention of [AIM2CERV] trial.

You’re misrepresenting my post. I did not assert that ADXS’ intention in selecting the adjuvant setting for phase-3 was, in fact, shady. Moreover, I found the reply by ‘glbeaty’ in #msg-133262496 persuasive.